pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    MRG-004A
    Solid Tumor Shanghai Miracogen Inc
  • Phase 2
    MRT-2359
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$GLUE Monte Rosa Therapeutics, Inc.
  • Phase 2
    MT-125
    Glioblastoma Multiforme (GBM) Myosin Therapeutics Inc
  • Phase 2
← prev
page 8 of 21
next →
131
Pain89
Neurology1
MTG-201
Prostate Cancer
Momotaro-Gene Inc
  • Phase 2
    MTL-CEBPA
    Hepatocellular Carcinoma Mina Therapeutics Ltd
  • Phase 2
    MVRT-3011
    Recurrent Head And Neck Squamous Cell Carcinoma Immvira Co Ltd
  • Phase 2
    MWTx-01
    Polycythemia Vera$IRON Disc Medicine, Inc.
  • Phase 2
    MesoCancerVac
    MesoPher
    Malignant Mesothelioma Amphera BV
  • Phase 2
    NB-003
    Gastrointestinal Stromal Tumor (GIST) NewBay Medical Technology Co Ltd
  • Phase 2
    NBM-BMX
    Metastatic Uveal Melanoma Novelwise Pharmaceutical Corp
  • Phase 2
    NC-410
    Cervical Cancer$NXTC NextCure, Inc.
  • Phase 2
    NEO-100
    Recurrent Glioblastoma Multiforme (GBM)$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Phase 2
    NEO-212
    Astrocytoma$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Phase 2
    NG-350A
    Epithelial Tumor Akamis Bio Ltd
  • Phase 2
    NOUS-209
    Gastric Cancer Nouscom AG
  • Phase 2
    NT-219
    Metastatic Colorectal Cancer$PPBT PURPLE BIOTECH LTD.
  • Phase 2
    NTX-301
    Chronic Myelomonocytic Leukemia (CMML) Pinotbio Inc
  • Phase 2
    NVX-108
    perflenapent
    Glioblastoma Multiforme (GBM) NuvOx Pharma LLC
  • Phase 2
    Nerofe
    Nerofe
    Refractory Acute Myeloid Leukemia Immune System Key Ltd
  • Phase 2
    OBI-902
    Bile Duct Cancer (Cholangiocarcinoma) OBI Pharma Inc
  • Phase 2
    OBX-115
    Metastatic Melanoma Obsidian Therapeutics Inc
  • Phase 2
    OMO-1
    Solid Tumor DeuterOncology NV
  • Phase 2
    ONC-841
    Colorectal Cancer OncoC4 Inc
  • Phase 2
    OXI-4503
    Refractory Acute Myeloid Leukemia$OTLC Oncotelic Therapeutics, Inc.
  • Phase 2
    OriCAR-017
    Refractory Multiple Myeloma Oricell Therapeutics (Shanghai) Co Ltd
  • Phase 2
    PAX-1
    Bile Duct Cancer (Cholangiocarcinoma) Komipharm International Co Ltd
  • Phase 2
    PBI-05204
    Metastatic Adenocarcinoma of The Pancreas Phoenix Biotechnology Inc
  • Phase 2
    PEEL-224
    Neuroblastoma Peel Therapeutics Inc
  • Phase 2
    PFL-002
    Non-Small Cell Lung Cancer Pierre Fabre Pharmaceuticals Inc
  • Phase 2
    PFL-241
    Non-Small Cell Lung Cancer Laboratoires Pierre Fabre SA